Syngen Biotech Co.,Ltd. (TPEX:8279)

Syngen Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	204.8	275.47	341.93	366.89	246.05	314.8
Cash & Short-Term Investments	204.8	275.47	341.93	366.89	246.05	314.8
Cash Growth	-8.09%	-19.44%	-6.80%	49.11%	-21.84%	-25.65%
Accounts Receivable	586.61	462.13	422.56	387.8	472.06	388.16
Other Receivables	8.99	0.01	0	0	0	0
Receivables	595.6	462.14	422.56	387.8	472.06	388.16
Inventory	433.67	361.67	345.62	348.99	369.35	291.96
Prepaid Expenses	37.86	41.91	44.93	28.77	25.42	23.17
Total Current Assets	1,272	1,141	1,155	1,132	1,113	1,018
Property, Plant & Equipment	1,439	1,459	1,518	1,526	1,543	1,035
Long-Term Investments	324.12	333.08	324.34	331.74	313.75	293.55
Other Intangible Assets	36.58	37.87	27.57	24.13	22.96	23.42
Long-Term Deferred Tax Assets	14.06	16.89	18.86	17.44	16.21	12.32
Other Long-Term Assets	74.1	58.22	38.4	73.21	58.7	28.23
Total Assets	3,161	3,048	3,085	3,106	3,071	2,416

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	296.6	234.75	255.87	226.47	248.45	236.86
Accrued Expenses	73.33	83.56	78.84	72.8	79.89	64.72
Short-Term Debt	-	-	-	80	230	-
Current Portion of Long-Term Debt	-	59.03	59.03	59.03	-	-
Current Portion of Leases	15.91	15.17	14.71	13.38	14.85	13.7
Current Income Taxes Payable	24.66	33.55	35.18	62.06	76.99	58.39
Current Unearned Revenue	66.38	37.16	24.83	20.04	6.73	6.55
Other Current Liabilities	191.9	56.37	51.7	50.81	62.56	38.4
Total Current Liabilities	668.77	519.58	520.16	584.58	719.47	418.61
Long-Term Debt	-	4.92	163.95	222.97	182	50
Long-Term Leases	145.79	146.08	160.25	163.1	173.93	172.39
Long-Term Deferred Tax Liabilities	3.32	4.32	4.17	3.98	3.93	3.16
Other Long-Term Liabilities	1.5	-	-	-	-	-
Total Liabilities	819.39	674.89	848.52	974.63	1,079	644.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	271.01	271.01	271.01	271.01	271.01	271.01
Additional Paid-In Capital	618.45	618.36	618.24	618.2	618.06	612.83
Retained Earnings	1,448	1,480	1,344	1,243	1,103	887.88
Comprehensive Income & Other	3.81	3.54	2.73	-0.26	-0.07	-0.36
Shareholders' Equity	2,341	2,373	2,236	2,132	1,992	1,771
Total Liabilities & Equity	3,161	3,048	3,085	3,106	3,071	2,416

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	161.7	225.19	397.93	538.49	600.78	236.08
Net Cash (Debt)	43.1	50.27	-56	-171.6	-354.73	78.72
Net Cash Growth	-	-	-	-	-	-54.53%
Net Cash Per Share	1.59	1.85	-2.06	-6.33	-13.07	2.90
Filing Date Shares Outstanding	27.1	27.1	27.1	27.1	27.1	27.1
Total Common Shares Outstanding	27.1	27.1	27.1	27.1	27.1	27.1
Working Capital	603.16	621.61	634.89	547.87	393.41	599.48
Book Value Per Share	86.39	87.57	82.51	78.66	73.49	65.36
Tangible Book Value	2,305	2,335	2,209	2,107	1,969	1,748
Tangible Book Value Per Share	85.04	86.17	81.49	77.76	72.64	64.50
Land	251	251	251	251	251	-
Buildings	823.91	820.48	729.7	717.09	702.28	532.98
Machinery	1,072	1,052	1,022	871.44	841.51	693.37
Construction In Progress	3.49	3.49	74.67	146.33	114.01	111.97

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error